| Date Filed | Type | Description |
| 09/23/2019 |
4
| MERRIWEATHER ALFRED G (CFO) has filed a Form 4 on Adamas Pharmaceuticals Inc|
Txns:
| Sold 1,584 shares
@ $6.91, valued at
$10.9k
|
|
| 04/10/2019 |
4
| MERRIWEATHER ALFRED G (CFO) has filed a Form 4 on Adamas Pharmaceuticals Inc|
Txns:
| Granted 25,000 shares
@ $0
Granted 50,000 options to buy
@ $6.81, valued at
$340.5k
|
|
| 03/21/2019 |
4
| MERRIWEATHER ALFRED G (CFO) has filed a Form 4 on Adamas Pharmaceuticals Inc|
Txns:
| Sold 857 shares
@ $7.99, valued at
$6.8k
|
|
| 09/21/2018 |
4
| MERRIWEATHER ALFRED G (CFO) has filed a Form 4 on Adamas Pharmaceuticals Inc|
Txns:
| Sold 1,665 shares
@ $19.18, valued at
$31.9k
|
|
| 03/09/2018 |
4
| MERRIWEATHER ALFRED G (CFO) has filed a Form 4 on Adamas Pharmaceuticals Inc|
Txns:
| Granted 8,375 shares
@ $0
Granted 50,250 options to buy
@ $25.66, valued at
$1.3M
|
|
| 07/10/2017 |
4
| MERRIWEATHER ALFRED G (CFO) has filed a Form 4 on Adamas Pharmaceuticals Inc|
Txns:
| Granted 18,750 shares
@ $0
Granted 112,500 options to buy
@ $16.98, valued at
$1.9M
|
|
| 07/06/2017 |
3
| MERRIWEATHER ALFRED G (CFO) has filed a Form 3 on Adamas Pharmaceuticals Inc |
| 05/19/2011 |
4
| MERRIWEATHER ALFRED G (SVP, CFO) has filed a Form 4 on Celera CORP|
Txns:
| Disposed/sold 50,000 options to buy
@ $6.3375, valued at
$316.9k
|
|
| 05/12/2011 |
4
| MERRIWEATHER ALFRED G (CFO) has filed a Form 4 on Celera CORP|
Txns:
| Unknown transaction of 15,828 shares
@ $8, valued at
$126.6k
|
|
| 05/06/2011 |
4
| MERRIWEATHER ALFRED G (CFO) has filed a Form 4 on Celera CORP|
Txns:
| Paid exercise price by delivering 9,172 shares
@ $8, valued at
$73.4k
|
|
| 01/04/2011 |
4
| MERRIWEATHER ALFRED G (CFO) has filed a Form 4 on Celera CORP|
Txns:
| Granted 25,000 shares
@ $0
Granted 50,000 options to buy
@ $6.3375, valued at
$316.9k
|
|
| 12/21/2010 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 01/22/2009 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
| 01/21/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |